Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Opioid Antitussives. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1139576C details a novel iridium-catalyzed asymmetric hydrogenation process for producing high-purity dextromethorphan intermediates with enhanced supply chain reliability.